MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Zentalis Pharmaceuticals, Inc. Common Stock

ZNTL

#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.39
-0.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
2.39
2.39
Intervallo Annuale
1.01
3.95
Variazione giornaliera
-0.42%
Variazione Mensile
-18.98%
Variazione di 6 mesi
+32.78%
Variazione Annuale
+17.73%
Chiusura Precedente
2.40
Open
2.39
Bid
Ask
Low
2.39
High
2.39
Volume
70
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. ZNTL
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Notizie

Investing Investing
ZNTL
2026.02.11
Zentalis Pharma CEO Eastland sells $21k in shares
Investing Investing
ZNTL
2026.02.11
Zentalis Pharma CMO Bruns sells $7998 in stock
Investing Investing
ZNTL
2026.02.05
Zentalis Pharmaceuticals: PAO vende azioni per 7.800 dollari
Seeking Alpha Seeking Alpha
ZNTL
2025.12.09
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Seeking Alpha Seeking Alpha
ZNTL
2025.11.18
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Investing Investing
ZNTL
2025.11.11
Obiettivo di prezzo di Zentalis Pharmaceuticals ridotto a $2 da Leerink Partners
Investing Investing
ZNTL
2025.11.11
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Investing Investing
ZNTL
2025.10.13
Zentalis to present azenosertib data at cancer therapeutics conference
Investing Investing
ZNTL
2025.06.18
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Investing Investing
ZNTL
2025.06.02
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing Investing
ZNTL
2025.06.02
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Investing Investing
ZNTL
2025.05.14
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd